INFINITUM ASSET MANAGEMENT, LLC

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 1 security · passive
ArriVent BioPharma, Inc. 13G/A
AVBP · 04272N102
9.9% 2/17/2026
Event 12/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.